Thursday 14 June 2018


Innovative Bioresearch is a secretly held biotech organization situated in Italy. Possessed and established by inquire about researcher Jonathan Fior with the objective of conveying advancement to the field, with an emphasis on HIV, malignancy and recovery look into. We are propelling a Token Sale for supporting our AIDS (Acquired Immunodeficiency Syndrome related with HIV disease) cure look into, and additionally to build up an application giving an on one hand a decentralized database for clinical information produced by our future human preliminaries, to beat the impediments of the momentum antiquated unified databases, and then again a social stage for the HIV seropositive network and our future administrations. We should begin by concentrating on the principal objective of this Token Sale, which is to help our AIDS cure examine, with a review of the flow province of SupT1 cell mixture treatment, the novel cell-based treatment for HIV brought about by Jonathan Fior, proprietor and boss logical officer of Innovative Bioresearch.

How Does Innovative Bioresearch Work?
For explore ventures, Jonathan Fior functions as PI (main examiner), considering the investigations and composing the examination convention. The work is then dispatched to a Contract Research Organization (CRO), which physically plays out the analyses. Jonathan Fior at that point regulates all perspectives identified with the exploration discussing intimately with the CRO. Once the trials are finished, he breaks down the outcomes and composes a logical paper, which is distributed in a companion looked into logical diary. This implies despite the fact that our group is certainly not a vast group, we really have organizations with 100+ individuals working for us. Along these lines we can keep a little, yet solid and awesome, group. We just distribute on open access logical diaries as we have faith in free data and don't need our information being taken cover behind a paywall.

One of our key destinations is to create recumbent cell imbuement treatment, our low cell-based treatment for HIV, to empower access to treatment for individuals who are normally left untreated because of social and/or financial restrictions. There are 36.7 million individuals tainted with HIV all around by 2016, 17.5 million are left untreated, as per unaids. We gauge our treatment to be less expensive than antiretroviral treatment (ART), which is traditional medication based treatment for HIV, and significantly more affordable than quality treatment items that utilization altered autologous cells offered by our rivals.
Token Name: INNBC
Platform: Ethereum
Type: ERC20
We have a hard cap of 50million INNBC. A 20million cap for the pre-sale, and a 30million cap for the sale.
We will use the additional funds to perform further clinical research (phase 4 trials) and we will also create a fund to provide our HIV treatment free of charge for patients who can't afford it.
We will organize a pre-ICO first. We will offer a 20% discount in the pre-sale (498INNBC per 1ETH), and a 10% discount in the successive sale (456INNBC per 1ETH). Regular emission price was set as 1EUR (1,23USD) per 1INNBC, corresponding to 415INNBC per 1ETH, with respect to the ETH/EUR exchange rate on the day of smart contract creation (16 April 2018).
Discount amount:
20% for Pre-ICO;
10% for the main Token Sales.
Minimum purchase size is 10 INNBC tokens.
Funds received after ICO will be distributed as follows:
50% of all funds will be spent on further research on AIDS treatment methods;
20% will be allocated for ecosystem development;
15% will be used to develop the application;
10% for stock JDM cars;
5% of the remaining funds will be used to maintain and maintain the application.
Access to use of INNBC tokens will be opened only after all crypto currencies have been sold out during ICO. Also, Innovative Bioresearch currency holders will be able to sell it to other users, thereby providing last access to the platform. Innovative Bioresearch wants to give all its investors something more, supporting INNBC-token values ​​also physically.


This bounty campaign will last for 8 WEEKS. The total of Bounty bonus to be paid to the participants is up to 3% of whole token supply, which will be determined by the results of the token sale(up to 1’500’000 INNBC tokens, 10 INNBC=10$ at presale, and 10 INNBC=15$ at main sale).
Bounty Allocation
  • Signature Bounty 40%
  • Youtube/Blog/Article/Visual/Infographic Bounty 45%
  • Twitter Bounty 5%
  • Facebook Bounty 5%
  • Translation Bounty 5%
General Rules
  • First week of the bounty campaign will start on the 23th of April 2018, Monday. The bounty campaign will end on the 17th of June 2018. Sundays are the last days of weekly periods.
  • Signature stakes will be distributed weekly. Other stakes will be calculated end of the campaign.
  • Stakes earned during the bounty campaign will be credited to the participants’ accounts within a week after the closing of the Bounty Campaign.
  • As a reward for the bounty activities, you will receive INNBC tokens. The tokens are allocated gradually to your wallet within 4 weeks after the end of the Crowdsale.
  • We reserve our right to eliminate you if we think you haven't been honest with your work.
  • We reserve the right to change bounty campaign rules.
  • Follower/Friend number cannot be changed during the campaign.
  • Using multi-accounts, cheating, using someone else to do the work and spamming or any kind of unethical behaviour when participating in one of the campaigns is not allowed and will get you disqualified from all bounties.
  • We are not looking for bounty hunters. We’re looking for supporters.
  • Reward system may change if we do not reach desired number of participants.
Website :
Whitepaper :
Facebook :
Twitter :
Ann Thread :
Bitcointalk profile link:;u=1925101
ETH Address: 0x5B606c2F10687e77dc7Fe644E429320C6a39Df63
DISCLAIMER:This post was brought to you by Opeyemi being my personal project on INNBC campaign project

No comments:

Post a Comment